Renteria O, Hu P, Schwab C, Yang Z, Dong J
Certain genetic variants correlate with heightened nausea sensitivity or slower gastric emptying, allowing your provider to start at a gentler dose or extend your dose escalation schedule
The BALANCE Model launching May 2026 is worth watching
The curve follows a characteristic pattern that researchers should anticipate
Primary risk factors Clinical studies have pinpointed four key predictors of semaglutide-related side effects: Gender Women have approximately 2.3 times higher odds of experiencing GI side effects compared to men Advancing age Each additional year of age modestly increases risk History of gastrointestinal disorders This is the strongest predictor, increasing odds by more than 6-fold Polypharmacy Taking multiple medications simultaneously increases risk Does taking metformin worsen semaglutide side effects
The Medicines and Healthcare products Regulatory Agency (MHRA) approved Mounjaro (tirzepatide) for weight loss and weight management for people aged 18 and over in November 2023
.jpg)
